BRAINBYSITE.TXT
Who has access

System properties
Type
Text
Size
577 KB
Storage used
577 KB
Location
Colab Notebooks
Owner
Whisper
Modified
May 27, 2021 by Whisper
Opened
9:01 AM by me
Created
8:57 AM
No description
Viewers can download
AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|37|198853824|Female|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|145|198853824|Female|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40145405|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39687165|Female|All other|2018|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Malignant|119|39687165|Female|All other|2018|0.2|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|45|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40632733|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40459557|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40208756|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40150534|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|155|198853824|Female|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40145405|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40164077|Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40141466|Female|Anaplastic astrocytoma|2017|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39687165|Female|Anaplastic astrocytoma|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40632733|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40459557|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|40305208|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|102|40208756|Female|Astrocytoma, NOS|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|103|40150534|Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|415|198853824|Female|Astrocytoma, NOS|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40145405|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40164077|Female|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|77|40141466|Female|Astrocytoma, NOS|2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|81|39687165|Female|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632733|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40459557|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40305208|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40305208|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40208756|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40208756|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40150534|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40150534|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|136|198853824|Female|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|41|198853824|Female|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|31|40145405|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40145405|Female|Choroid plexus|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40164077|Female|Choroid plexus|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Choroid plexus|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40141466|Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Choroid plexus|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|39687165|Female|Choroid plexus|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Choroid plexus|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40632733|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|40459557|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40305208|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40208756|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40150534|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|366|198853824|Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|198853824|Female|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|40145405|Female|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40164077|Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40164077|Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40141466|Female|Craniopharyngioma|2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40141466|Female|Craniopharyngioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|39687165|Female|Craniopharyngioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40632733|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|220|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|205|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|175|40632733|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40459557|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|40305208|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|40208756|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|212|40150534|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.4|0.5|0.5|Malignant|896|198853824|Female|Embryonal/primitive/medulloblastoma|2014-2018|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|191|40145405|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.4|0.5|0.4|Malignant|178|40164077|Female|Embryonal/primitive/medulloblastoma|2016|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.4|0.5|0.4|Malignant|170|40141466|Female|Embryonal/primitive/medulloblastoma|2017|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.3|0.5|0.4|Malignant|152|39687165|Female|Embryonal/primitive/medulloblastoma|2018|0.3|0.4|0.4
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40459557|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305208|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40305208|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40208756|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40208756|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|59|198853824|Female|Ependymoma variants|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|198853824|Female|Ependymoma variants|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40632733|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40459557|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40305208|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40208756|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40150534|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|419|198853824|Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40145405|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|79|40164077|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40141466|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|39687165|Female|Ependymoma/anaplastic ependymoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40632733|Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|53|40632733|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40459557|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|36|40459557|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305208|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|21|40305208|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40208756|Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|47|40208756|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40150534|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40150534|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|104|198853824|Female|Germ Cell Tumors|2014-2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|222|198853824|Female|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40145405|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|46|40145405|Female|Germ Cell Tumors|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|40164077|Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|58|40164077|Female|Germ Cell Tumors|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Germ Cell Tumors|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40141466|Female|Germ Cell Tumors|2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|39687165|Female|Germ Cell Tumors|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|40|39687165|Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40632733|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40459557|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40305208|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40208756|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40150534|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Glioblastoma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|311|198853824|Female|Glioblastoma|2014-2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40145405|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|40164077|Female|Glioblastoma|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|40141466|Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.1|Malignant|54|39687165|Female|Glioblastoma|2018|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|234|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|237|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|268|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|297|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|264|40632733|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|20|40459557|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|312|40459557|Female|Glioma malignant, NOS|2011|0.7|0.9|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40305208|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|227|40305208|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.7|0.8|0.8|Malignant|304|40208756|Female|Glioma malignant, NOS|2013|0.7|0.8|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40150534|Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|271|40150534|Female|Glioma malignant, NOS|2014|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|99|198853824|Female|Glioma malignant, NOS|2014-2018|0.0|0.1|0.0
0-19|0.7|0.7|0.7|Malignant|1396|198853824|Female|Glioma malignant, NOS|2014-2018|0.7|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|16|40145405|Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|278|40145405|Female|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|23|40164077|Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|312|40164077|Female|Glioma malignant, NOS|2016|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|21|40141466|Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|310|40141466|Female|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|22|39687165|Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.7|0.6|Malignant|236|39687165|Female|Glioma malignant, NOS|2018|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40670476|Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40459557|Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40459557|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40208756|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40208756|Female|Hemangioblastoma|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|40150534|Female|Hemangioblastoma|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40150534|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|101|198853824|Female|Hemangioblastoma|2014-2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|198853824|Female|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40145405|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40145405|Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40164077|Female|Hemangioblastoma|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Hemangioblastoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39687165|Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39687165|Female|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39865121|Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40576293|Female|Hemangioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|40632733|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|40459557|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40305208|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40208756|Female|Hemangioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40150534|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|290|198853824|Female|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|198853824|Female|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|40145405|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|40164077|Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|40141466|Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39687165|Female|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|198853824|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40632733|Female|Meningioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40459557|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40305208|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Meningioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40208756|Female|Meningioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40150534|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|330|198853824|Female|Meningioma|2014-2018|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|198853824|Female|Meningioma|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|68|40145405|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|40164077|Female|Meningioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40164077|Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40141466|Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40141466|Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|39687165|Female|Meningioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|198853824|Female|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|57|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|78|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40632733|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40459557|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|40305208|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|74|40208756|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40208756|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|80|40150534|Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40150534|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|323|198853824|Female|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|103|198853824|Female|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|81|40145405|Female|Neoplasm, unspecified|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Neoplasm, unspecified|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40164077|Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40164077|Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|49|40141466|Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|21|40141466|Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|62|39687165|Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|39687165|Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Nerve sheath, benign and malignant|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|40632733|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40459557|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40305208|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305208|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|40208756|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40208756|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40150534|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40150534|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|583|198853824|Female|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198853824|Female|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40145405|Female|Nerve sheath, benign and malignant|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40145405|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40164077|Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40164077|Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40141466|Female|Nerve sheath, benign and malignant|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39687165|Female|Nerve sheath, benign and malignant|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39687165|Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Neuroepithelial|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|198853824|Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Neuroepithelial|2018|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|124|40165421|Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|134|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40632733|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|19|40632733|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|154|40459557|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40459557|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40305208|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|40305208|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|160|40208756|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|40208756|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|160|40150534|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40150534|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|829|198853824|Female|Neuronal/glial, neuronal|2014-2018|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|119|198853824|Female|Neuronal/glial, neuronal|2014-2018|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|170|40145405|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40145405|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|186|40164077|Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|29|40164077|Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|170|40141466|Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|22|40141466|Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|148|39687165|Female|Neuronal/glial, neuronal|2018|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|27|39687165|Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40632733|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40305208|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40208756|Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40150534|Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|81|198853824|Female|Oligodendroglioma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40145405|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40164077|Female|Oligodendroglioma|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40632733|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40459557|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40305208|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40305208|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40208756|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40208756|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|40150534|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40150534|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|231|198853824|Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|27|198853824|Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|40145405|Female|Other mesenchymal|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40145405|Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40164077|Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|40141466|Female|Other mesenchymal|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|39687165|Female|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|323|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|319|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|339|40382360|Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|336|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|355|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|397|40632733|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|355|40459557|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|382|40305208|Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|365|40208756|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|407|40150534|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|0.0|0.0|0.0|Benign/Borderline|72|198853824|Female|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|1.0|0.9|Malignant|1804|198853824|Female|Pilocytic astrocytoma|2014-2018|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|358|40145405|Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.7|0.9|0.8|Malignant|325|40164077|Female|Pilocytic astrocytoma|2016|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Pilocytic astrocytoma|2017|~|~|~
0-19|0.9|1.1|1.0|Malignant|399|40141466|Female|Pilocytic astrocytoma|2017|0.9|1.1|1.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|39687165|Female|Pilocytic astrocytoma|2018|0.1|0.2|0.2
0-19|0.7|0.9|0.8|Malignant|329|39687165|Female|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40150534|Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|20|198853824|Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|86|198853824|Female|Pineal parenchymal|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40145405|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Pineal parenchymal|2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|39687165|Female|Pineal parenchymal|2018|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Benign/Borderline|277|39865121|Female|Pituitary|2004|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|318|39998876|Female|Pituitary|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|363|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|347|40382360|Female|Pituitary|2007|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|404|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|404|40670476|Female|Pituitary|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|466|40632733|Female|Pituitary|2010|1.0|1.3|1.1
0-19|~|~|~|Malignant|~|40632733|Female|Pituitary|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|471|40459557|Female|Pituitary|2011|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40459557|Female|Pituitary|2011|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|503|40305208|Female|Pituitary|2012|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|40305208|Female|Pituitary|2012|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|483|40208756|Female|Pituitary|2013|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40208756|Female|Pituitary|2013|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|532|40150534|Female|Pituitary|2014|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40150534|Female|Pituitary|2014|~|~|~
0-19|1.3|1.4|1.3|Benign/Borderline|2681|198853824|Female|Pituitary|2014-2018|1.3|1.4|1.3
0-19|~|~|~|Malignant|~|198853824|Female|Pituitary|2014-2018|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|523|40145405|Female|Pituitary|2015|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40145405|Female|Pituitary|2015|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|564|40164077|Female|Pituitary|2016|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40164077|Female|Pituitary|2016|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|563|40141466|Female|Pituitary|2017|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40141466|Female|Pituitary|2017|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|514|39687165|Female|Pituitary|2018|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|39687165|Female|Pituitary|2018|~|~|~
0-19|1.9|2.1|2.0|Benign/Borderline|799|39865121|Female|Total|2004|1.9|2.1|2.0
0-19|3.1|3.5|3.3|Malignant|1307|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.2|2.5|2.4|Benign/Borderline|965|39998876|Female|Total|2005|2.3|2.6|2.4
0-19|2.9|3.3|3.1|Malignant|1239|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|981|40165421|Female|Total|2006|2.3|2.6|2.4
0-19|2.9|3.2|3.1|Malignant|1228|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|993|40382360|Female|Total|2007|2.3|2.6|2.5
0-19|3.1|3.4|3.2|Malignant|1302|40382360|Female|Total|2007|3.1|3.4|3.2
0-19|2.5|2.8|2.6|Benign/Borderline|1082|40576293|Female|Total|2008|2.5|2.8|2.7
0-19|3.0|3.4|3.2|Malignant|1288|40576293|Female|Total|2008|3.0|3.4|3.2
0-19|2.5|2.8|2.7|Benign/Borderline|1103|40670476|Female|Total|2009|2.6|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1299|40670476|Female|Total|2009|3.0|3.4|3.2
0-19|2.7|3.0|2.9|Benign/Borderline|1180|40632733|Female|Total|2010|2.7|3.1|2.9
0-19|3.1|3.4|3.2|Malignant|1307|40632733|Female|Total|2010|3.0|3.4|3.2
0-19|2.8|3.1|3.0|Benign/Borderline|1215|40459557|Female|Total|2011|2.8|3.2|3.0
0-19|3.2|3.5|3.3|Malignant|1353|40459557|Female|Total|2011|3.2|3.5|3.3
0-19|2.9|3.3|3.1|Benign/Borderline|1266|40305208|Female|Total|2012|3.0|3.3|3.1
0-19|2.9|3.3|3.1|Malignant|1239|40305208|Female|Total|2012|2.9|3.3|3.1
0-19|3.0|3.4|3.2|Benign/Borderline|1287|40208756|Female|Total|2013|3.0|3.4|3.2
0-19|3.2|3.6|3.4|Malignant|1362|40208756|Female|Total|2013|3.2|3.6|3.4
0-19|3.0|3.4|3.2|Benign/Borderline|1295|40150534|Female|Total|2014|3.1|3.4|3.2
0-19|3.3|3.6|3.4|Malignant|1383|40150534|Female|Total|2014|3.3|3.6|3.4
0-19|3.1|3.3|3.2|Benign/Borderline|6355|198853824|Female|Total|2014-2018|3.1|3.3|3.2
0-19|3.1|3.3|3.2|Malignant|6324|198853824|Female|Total|2014-2018|3.1|3.3|3.2
0-19|3.1|3.5|3.3|Benign/Borderline|1325|40145405|Female|Total|2015|3.1|3.5|3.3
0-19|3.0|3.4|3.2|Malignant|1287|40145405|Female|Total|2015|3.0|3.4|3.2
0-19|3.1|3.4|3.2|Benign/Borderline|1312|40164077|Female|Total|2016|3.1|3.4|3.3
0-19|3.0|3.4|3.2|Malignant|1272|40164077|Female|Total|2016|3.0|3.3|3.2
0-19|3.0|3.3|3.1|Benign/Borderline|1270|40141466|Female|Total|2017|3.0|3.3|3.2
0-19|3.1|3.5|3.3|Malignant|1316|40141466|Female|Total|2017|3.1|3.5|3.3
0-19|2.8|3.2|3.0|Benign/Borderline|1193|39687165|Female|Total|2018|2.8|3.2|3.0
0-19|2.7|3.0|2.8|Malignant|1116|39687165|Female|Total|2018|2.6|3.0|2.8
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|40632733|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40459557|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40305208|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|40208756|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40150534|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|583|198853824|Female|Tumors of Cranial and Spinal Nerves|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198853824|Female|Tumors of Cranial and Spinal Nerves|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40145405|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40164077|Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40141466|Female|Tumors of Cranial and Spinal Nerves|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39687165|Female|Tumors of Cranial and Spinal Nerves|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|191|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1209|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|198|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1148|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|204|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1158|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|229|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.3|3.1|Malignant|1239|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|229|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1233|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|215|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1219|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|233|40632733|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1226|40632733|Female|Tumors of Neuroepthelial Tissue|2010|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|248|40459557|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|1274|40459557|Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|254|40305208|Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.8|3.1|2.9|Malignant|1176|40305208|Female|Tumors of Neuroepthelial Tissue|2012|2.8|3.1|2.9
0-19|0.6|0.7|0.7|Benign/Borderline|264|40208756|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.7
0-19|3.0|3.3|3.2|Malignant|1273|40208756|Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.3|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|251|40150534|Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1309|40150534|Female|Tumors of Neuroepthelial Tissue|2014|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|1346|198853824|Female|Tumors of Neuroepthelial Tissue|2014-2018|0.6|0.7|0.7
0-19|2.9|3.1|3.0|Malignant|5913|198853824|Female|Tumors of Neuroepthelial Tissue|2014-2018|2.9|3.1|3.0
0-19|0.6|0.7|0.6|Benign/Borderline|254|40145405|Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.6
0-19|2.8|3.2|3.0|Malignant|1204|40145405|Female|Tumors of Neuroepthelial Tissue|2015|2.8|3.2|3.0
0-19|0.6|0.8|0.7|Benign/Borderline|277|40164077|Female|Tumors of Neuroepthelial Tissue|2016|0.6|0.8|0.7
0-19|2.7|3.1|2.9|Malignant|1169|40164077|Female|Tumors of Neuroepthelial Tissue|2016|2.7|3.1|2.9
0-19|0.6|0.8|0.7|Benign/Borderline|268|40141466|Female|Tumors of Neuroepthelial Tissue|2017|0.6|0.8|0.7
0-19|2.9|3.3|3.1|Malignant|1238|40141466|Female|Tumors of Neuroepthelial Tissue|2017|2.9|3.3|3.1
0-19|0.7|0.9|0.8|Benign/Borderline|308|39687165|Female|Tumors of Neuroepthelial Tissue|2018|0.7|0.9|0.8
0-19|2.5|2.8|2.6|Malignant|1038|39687165|Female|Tumors of Neuroepthelial Tissue|2018|2.5|2.8|2.6
0-19|0.8|1.0|0.9|Benign/Borderline|361|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|396|39998876|Female|Tumors of Sellar Region|2005|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|440|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|443|40382360|Female|Tumors of Sellar Region|2007|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|470|40576293|Female|Tumors of Sellar Region|2008|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|495|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|558|40632733|Female|Tumors of Sellar Region|2010|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.5|1.4|Benign/Borderline|558|40459557|Female|Tumors of Sellar Region|2011|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|581|40305208|Female|Tumors of Sellar Region|2012|1.3|1.6|1.4
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|572|40208756|Female|Tumors of Sellar Region|2013|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.4|1.7|1.5|Benign/Borderline|624|40150534|Female|Tumors of Sellar Region|2014|1.4|1.7|1.6
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.5|1.6|1.5|Benign/Borderline|3047|198853824|Female|Tumors of Sellar Region|2014-2018|1.5|1.6|1.5
0-19|~|~|~|Malignant|~|198853824|Female|Tumors of Sellar Region|2014-2018|~|~|~
0-19|1.4|1.6|1.5|Benign/Borderline|604|40145405|Female|Tumors of Sellar Region|2015|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.4|1.7|1.6|Benign/Borderline|632|40164077|Female|Tumors of Sellar Region|2016|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|642|40141466|Female|Tumors of Sellar Region|2017|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of Sellar Region|2017|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|565|39687165|Female|Tumors of Sellar Region|2018|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of Sellar Region|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|103|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|101|40632733|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40459557|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40305208|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|40208756|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40150534|Female|Tumors of the Meninges|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|662|198853824|Female|Tumors of the Meninges|2014-2018|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|46|198853824|Female|Tumors of the Meninges|2014-2018|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|135|40145405|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|142|40164077|Female|Tumors of the Meninges|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40141466|Female|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of the Meninges|2017|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|39687165|Female|Tumors of the Meninges|2018|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of the Meninges|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|39865121|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|81|39998876|Female|Unclassified Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|83|40382360|Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|40576293|Female|Unclassified Tumors|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|133|40632733|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40459557|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|140|40305208|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40208756|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40208756|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|146|40150534|Female|Unclassified Tumors|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|24|40150534|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|613|198853824|Female|Unclassified Tumors|2014-2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|109|198853824|Female|Unclassified Tumors|2014-2018|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|155|40145405|Female|Unclassified Tumors|2015|0.3|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40145405|Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|107|40164077|Female|Unclassified Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|25|40164077|Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|101|40141466|Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|40141466|Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|109|39687165|Female|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|39687165|Female|Unclassified Tumors|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|30|40632733|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40459557|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|23|40459557|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|34|40305208|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40305208|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|40208756|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40208756|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|41|40150534|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40150534|Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|121|198853824|Female|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|108|198853824|Female|Unique astrocytoma variants|2014-2018|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40145405|Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|26|40145405|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40164077|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|21|40164077|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40141466|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|40141466|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39687165|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|39687165|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|35|207689081|Male|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|155|207689081|Male|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41934839|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|41442486|Male|All other|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|117|41442486|Male|All other|2018|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42549015|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42367323|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42176956|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|42036128|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|41955322|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|215|207689081|Male|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|41934839|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|41942505|Male|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|41921243|Male|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41442486|Male|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|42549015|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|104|42367323|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42176956|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42036128|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|41955322|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|483|207689081|Male|Astrocytoma, NOS|2014-2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41934839|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|41942505|Male|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41921243|Male|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|41442486|Male|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42549015|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|42549015|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42367323|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42176956|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42036128|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41955322|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|177|207689081|Male|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|60|207689081|Male|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|41934839|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41934839|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|41942505|Male|Choroid plexus|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Choroid plexus|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41921243|Male|Choroid plexus|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Choroid plexus|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|41442486|Male|Choroid plexus|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Choroid plexus|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|41889233|Male|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42609915|Male|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42549015|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42549015|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|42367323|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|79|42176956|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42176956|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42036128|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42036128|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|41955322|Male|Craniopharyngioma|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41955322|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|468|207689081|Male|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|207689081|Male|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|41934839|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41934839|Male|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|41942505|Male|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41942505|Male|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|100|41921243|Male|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41921243|Male|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|41442486|Male|Craniopharyngioma|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42367323|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42176956|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Diffuse astrocytoma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|207689081|Male|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|295|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|299|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|322|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|314|42549015|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|42367323|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42176956|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|273|42036128|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.8|0.7|Malignant|281|41955322|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.6|0.7|0.7|Malignant|1355|207689081|Male|Embryonal/primitive/medulloblastoma|2014-2018|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|41934839|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.6|0.8|0.7|Malignant|288|41942505|Male|Embryonal/primitive/medulloblastoma|2016|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.6|0.8|0.7|Malignant|300|41921243|Male|Embryonal/primitive/medulloblastoma|2017|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.6|0.5|Malignant|198|41442486|Male|Embryonal/primitive/medulloblastoma|2018|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42549015|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42367323|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42176956|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42176956|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42036128|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42036128|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|86|207689081|Male|Ependymoma variants|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|207689081|Male|Ependymoma variants|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41934839|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41934839|Male|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|41942505|Male|Ependymoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|41921243|Male|Ependymoma variants|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41442486|Male|Ependymoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42549015|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367323|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42176956|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42036128|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41955322|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.3|0.3|Malignant|535|207689081|Male|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|41934839|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41942505|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|41921243|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|41442486|Male|Ependymoma/anaplastic ependymoma|2018|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|28|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|103|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|100|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|29|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|42549015|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|112|42549015|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|42367323|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|23|42176956|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42176956|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42036128|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42036128|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41955322|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|102|41955322|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|133|207689081|Male|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|530|207689081|Male|Germ Cell Tumors|2014-2018|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|19|41934839|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|106|41934839|Male|Germ Cell Tumors|2015|0.2|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|33|41942505|Male|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|41942505|Male|Germ Cell Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41921243|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|129|41921243|Male|Germ Cell Tumors|2017|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|31|41442486|Male|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|87|41442486|Male|Germ Cell Tumors|2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42549015|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|42367323|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42176956|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|42036128|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41955322|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Glioblastoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|387|207689081|Male|Glioblastoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41934839|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Glioblastoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41942505|Male|Glioblastoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|41921243|Male|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41442486|Male|Glioblastoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|228|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|223|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42158997|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42549015|Male|Glioma malignant, NOS|2010|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|283|42367323|Male|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|42176956|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|281|42176956|Male|Glioma malignant, NOS|2012|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|42036128|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|273|42036128|Male|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|23|41955322|Male|Glioma malignant, NOS|2014|0.0|0.1|0.1
0-19|0.6|0.7|0.6|Malignant|264|41955322|Male|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.1|0.1|0.1|Benign/Borderline|127|207689081|Male|Glioma malignant, NOS|2014-2018|0.1|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|1388|207689081|Male|Glioma malignant, NOS|2014-2018|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|22|41934839|Male|Glioma malignant, NOS|2015|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|304|41934839|Male|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|30|41942505|Male|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|296|41942505|Male|Glioma malignant, NOS|2016|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|22|41921243|Male|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|322|41921243|Male|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.1|0.1|0.1|Benign/Borderline|31|41442486|Male|Glioma malignant, NOS|2018|0.1|0.1|0.1
0-19|0.4|0.6|0.5|Malignant|209|41442486|Male|Glioma malignant, NOS|2018|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42367323|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42176956|Male|Hemangioblastoma|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42036128|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42036128|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41955322|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41955322|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|90|207689081|Male|Hemangioblastoma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|207689081|Male|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41934839|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41934839|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41942505|Male|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41942505|Male|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41921243|Male|Hemangioblastoma|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Hemangioblastoma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Hemangioblastoma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41889233|Male|Hemangioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42549015|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|42367323|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|42176956|Male|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42176956|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42036128|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41955322|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|306|207689081|Male|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|207689081|Male|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|41934839|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41934839|Male|Hemangioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41942505|Male|Hemangioma|2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41942505|Male|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|41921243|Male|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|41442486|Male|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|43|207689081|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42549015|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|42367323|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|42176956|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42036128|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41955322|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|316|207689081|Male|Meningioma|2014-2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|207689081|Male|Meningioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|41934839|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41934839|Male|Meningioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41942505|Male|Meningioma|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41921243|Male|Meningioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|41442486|Male|Meningioma|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42549015|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|207689081|Male|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|54|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|91|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|80|42549015|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42549015|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|71|42367323|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Neoplasm, unspecified|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42176956|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|29|42176956|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|42036128|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42036128|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|41955322|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41955322|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|329|207689081|Male|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|110|207689081|Male|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|41934839|Male|Neoplasm, unspecified|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|21|41934839|Male|Neoplasm, unspecified|2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|67|41942505|Male|Neoplasm, unspecified|2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|41942505|Male|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|41921243|Male|Neoplasm, unspecified|2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|29|41921243|Male|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|41442486|Male|Neoplasm, unspecified|2018|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|41442486|Male|Neoplasm, unspecified|2018|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|173|42158997|Male|Nerve sheath, benign and malignant|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42549015|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367323|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367323|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42176956|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|163|42036128|Male|Nerve sheath, benign and malignant|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|147|41955322|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955322|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|674|207689081|Male|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|207689081|Male|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|41934839|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|41942505|Male|Nerve sheath, benign and malignant|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41942505|Male|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|41921243|Male|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41442486|Male|Nerve sheath, benign and malignant|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Neuroepithelial|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Neuroepithelial|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Neuroepithelial|2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|174|42367071|Male|Neuronal/glial, neuronal|2007|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|178|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|173|42549015|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42549015|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|190|42367323|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|21|42367323|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|42176956|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|20|42176956|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|191|42036128|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|42036128|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|173|41955322|Male|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|31|41955322|Male|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.5|0.5|0.5|Benign/Borderline|1033|207689081|Male|Neuronal/glial, neuronal|2014-2018|0.5|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|121|207689081|Male|Neuronal/glial, neuronal|2014-2018|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|216|41934839|Male|Neuronal/glial, neuronal|2015|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41934839|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|226|41942505|Male|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41942505|Male|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|227|41921243|Male|Neuronal/glial, neuronal|2017|0.5|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|17|41921243|Male|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|197|41442486|Male|Neuronal/glial, neuronal|2018|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|41442486|Male|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42549015|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367323|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42176956|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42036128|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41955322|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|80|207689081|Male|Oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41934839|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41942505|Male|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549015|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367323|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|42176956|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42036128|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41955322|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|207|207689081|Male|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|37|207689081|Male|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|41934839|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41934839|Male|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|41942505|Male|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|41921243|Male|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|41442486|Male|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|352|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|358|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|348|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|396|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|366|42609915|Male|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|378|42549015|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|400|42367323|Male|Pilocytic astrocytoma|2011|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|425|42176956|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|434|42036128|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|381|41955322|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|0.0|0.0|0.0|Benign/Borderline|60|207689081|Male|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|1.0|0.9|Malignant|1911|207689081|Male|Pilocytic astrocytoma|2014-2018|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|381|41934839|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|1.0|0.9|Malignant|382|41942505|Male|Pilocytic astrocytoma|2016|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Pilocytic astrocytoma|2017|~|~|~
0-19|1.0|1.2|1.0|Malignant|439|41921243|Male|Pilocytic astrocytoma|2017|1.0|1.1|1.0
0-19|0.1|0.2|0.1|Benign/Borderline|60|41442486|Male|Pilocytic astrocytoma|2018|0.1|0.2|0.1
0-19|0.7|0.9|0.8|Malignant|337|41442486|Male|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42367323|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42176956|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42036128|Male|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41955322|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|16|207689081|Male|Pineal parenchymal|2014-2018|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|93|207689081|Male|Pineal parenchymal|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41934839|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41942505|Male|Pineal parenchymal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Pineal parenchymal|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Pineal parenchymal|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|123|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549015|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42367323|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367323|Male|Pituitary|2011|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|179|42176956|Male|Pituitary|2012|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Pituitary|2012|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|176|42036128|Male|Pituitary|2013|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|194|41955322|Male|Pituitary|2014|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41955322|Male|Pituitary|2014|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|940|207689081|Male|Pituitary|2014-2018|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|207689081|Male|Pituitary|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|163|41934839|Male|Pituitary|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Pituitary|2015|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|197|41942505|Male|Pituitary|2016|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41942505|Male|Pituitary|2016|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|223|41921243|Male|Pituitary|2017|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|41921243|Male|Pituitary|2017|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|168|41442486|Male|Pituitary|2018|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41442486|Male|Pituitary|2018|~|~|~
0-19|1.5|1.8|1.6|Benign/Borderline|688|41889233|Male|Total|2004|1.5|1.8|1.6
0-19|3.4|3.8|3.6|Malignant|1505|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.9|Benign/Borderline|788|42006384|Male|Total|2005|1.7|2.0|1.9
0-19|3.2|3.6|3.4|Malignant|1431|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|811|42158997|Male|Total|2006|1.8|2.1|1.9
0-19|3.4|3.8|3.6|Malignant|1513|42158997|Male|Total|2006|3.4|3.8|3.6
0-19|1.9|2.1|2.0|Benign/Borderline|853|42367071|Male|Total|2007|1.9|2.2|2.0
0-19|3.4|3.8|3.6|Malignant|1525|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.9|2.2|2.0|Benign/Borderline|867|42541971|Male|Total|2008|1.9|2.2|2.0
0-19|3.6|4.0|3.8|Malignant|1608|42541971|Male|Total|2008|3.6|4.0|3.8
0-19|2.1|2.4|2.2|Benign/Borderline|949|42609915|Male|Total|2009|2.1|2.4|2.2
0-19|3.5|3.9|3.7|Malignant|1557|42609915|Male|Total|2009|3.5|3.8|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|901|42549015|Male|Total|2010|2.0|2.3|2.1
0-19|3.6|4.0|3.8|Malignant|1607|42549015|Male|Total|2010|3.6|4.0|3.8
0-19|2.1|2.4|2.3|Benign/Borderline|961|42367323|Male|Total|2011|2.1|2.4|2.3
0-19|3.6|4.0|3.8|Malignant|1599|42367323|Male|Total|2011|3.6|4.0|3.8
0-19|2.3|2.6|2.4|Benign/Borderline|1016|42176956|Male|Total|2012|2.3|2.6|2.4
0-19|3.7|4.0|3.8|Malignant|1618|42176956|Male|Total|2012|3.7|4.0|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|1000|42036128|Male|Total|2013|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1598|42036128|Male|Total|2013|3.6|4.0|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|1004|41955322|Male|Total|2014|2.2|2.5|2.4
0-19|3.6|3.9|3.7|Malignant|1565|41955322|Male|Total|2014|3.5|3.9|3.7
0-19|2.4|2.5|2.5|Benign/Borderline|5154|207689081|Male|Total|2014-2018|2.4|2.6|2.5
0-19|3.6|3.7|3.7|Malignant|7576|207689081|Male|Total|2014-2018|3.6|3.7|3.6
0-19|2.2|2.5|2.4|Benign/Borderline|992|41934839|Male|Total|2015|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1598|41934839|Male|Total|2015|3.6|4.0|3.8
0-19|2.5|2.8|2.6|Benign/Borderline|1105|41942505|Male|Total|2016|2.5|2.8|2.6
0-19|3.5|3.9|3.7|Malignant|1563|41942505|Male|Total|2016|3.5|3.9|3.7
0-19|2.4|2.7|2.5|Benign/Borderline|1051|41921243|Male|Total|2017|2.4|2.7|2.5
0-19|3.8|4.1|4.0|Malignant|1654|41921243|Male|Total|2017|3.8|4.1|3.9
0-19|2.3|2.6|2.5|Benign/Borderline|1023|41442486|Male|Total|2018|2.3|2.6|2.5
0-19|2.9|3.2|3.0|Malignant|1254|41442486|Male|Total|2018|2.9|3.2|3.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|173|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42549015|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367323|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42176956|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|164|42036128|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|41955322|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|676|207689081|Male|Tumors of Cranial and Spinal Nerves|2014-2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|207689081|Male|Tumors of Cranial and Spinal Nerves|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|41934839|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|41942505|Male|Tumors of Cranial and Spinal Nerves|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|41921243|Male|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41442486|Male|Tumors of Cranial and Spinal Nerves|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|233|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.6
0-19|3.1|3.5|3.3|Malignant|1363|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|261|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1297|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|260|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1363|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|269|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1377|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|281|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1445|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.6|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|275|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1413|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|286|42549015|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1451|42549015|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|310|42367323|Male|Tumors of Neuroepthelial Tissue|2011|0.7|0.8|0.7
0-19|3.3|3.6|3.5|Malignant|1462|42367323|Male|Tumors of Neuroepthelial Tissue|2011|3.3|3.6|3.5
0-19|0.7|0.8|0.8|Benign/Borderline|321|42176956|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.8|0.8
0-19|3.3|3.6|3.4|Malignant|1450|42176956|Male|Tumors of Neuroepthelial Tissue|2012|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|306|42036128|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1441|42036128|Male|Tumors of Neuroepthelial Tissue|2013|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|288|41955322|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1415|41955322|Male|Tumors of Neuroepthelial Tissue|2014|3.2|3.6|3.4
0-19|0.8|0.9|0.8|Benign/Borderline|1687|207689081|Male|Tumors of Neuroepthelial Tissue|2014-2018|0.8|0.9|0.8
0-19|3.2|3.4|3.3|Malignant|6817|207689081|Male|Tumors of Neuroepthelial Tissue|2014-2018|3.2|3.4|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|321|41934839|Male|Tumors of Neuroepthelial Tissue|2015|0.7|0.9|0.8
0-19|3.3|3.6|3.4|Malignant|1442|41934839|Male|Tumors of Neuroepthelial Tissue|2015|3.3|3.6|3.4
0-19|0.8|1.0|0.9|Benign/Borderline|360|41942505|Male|Tumors of Neuroepthelial Tissue|2016|0.8|1.0|0.9
0-19|3.2|3.5|3.3|Malignant|1403|41942505|Male|Tumors of Neuroepthelial Tissue|2016|3.2|3.5|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|335|41921243|Male|Tumors of Neuroepthelial Tissue|2017|0.7|0.9|0.8
0-19|3.3|3.7|3.5|Malignant|1476|41921243|Male|Tumors of Neuroepthelial Tissue|2017|3.3|3.7|3.5
0-19|0.9|1.0|0.9|Benign/Borderline|392|41442486|Male|Tumors of Neuroepthelial Tissue|2018|0.9|1.0|0.9
0-19|2.6|2.9|2.7|Malignant|1131|41442486|Male|Tumors of Neuroepthelial Tissue|2018|2.6|2.9|2.7
0-19|0.3|0.5|0.4|Benign/Borderline|171|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|217|42006384|Male|Tumors of Sellar Region|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|177|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|201|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|231|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|239|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|223|42549015|Male|Tumors of Sellar Region|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42367323|Male|Tumors of Sellar Region|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|258|42176956|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|269|42036128|Male|Tumors of Sellar Region|2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|300|41955322|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|1408|207689081|Male|Tumors of Sellar Region|2014-2018|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|207689081|Male|Tumors of Sellar Region|2014-2018|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|259|41934839|Male|Tumors of Sellar Region|2015|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|271|41942505|Male|Tumors of Sellar Region|2016|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of Sellar Region|2016|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|323|41921243|Male|Tumors of Sellar Region|2017|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of Sellar Region|2017|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|264|41442486|Male|Tumors of Sellar Region|2018|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of Sellar Region|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42367071|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42549015|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|42367323|Male|Tumors of the Meninges|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|42176956|Male|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|108|42036128|Male|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|41955322|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|613|207689081|Male|Tumors of the Meninges|2014-2018|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|48|207689081|Male|Tumors of the Meninges|2014-2018|0.0|0.0|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|124|41934839|Male|Tumors of the Meninges|2015|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|41942505|Male|Tumors of the Meninges|2016|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|41921243|Male|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of the Meninges|2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|41442486|Male|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of the Meninges|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|90|42158997|Male|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|153|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|135|42549015|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42549015|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|141|42367323|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|42367323|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|127|42176956|Male|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|42176956|Male|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|127|42036128|Male|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|42036128|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|128|41955322|Male|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41955322|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|637|207689081|Male|Unclassified Tumors|2014-2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|115|207689081|Male|Unclassified Tumors|2014-2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|41934839|Male|Unclassified Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|41934839|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|150|41942505|Male|Unclassified Tumors|2016|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|41942505|Male|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|129|41921243|Male|Unclassified Tumors|2017|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|30|41921243|Male|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|113|41442486|Male|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|41442486|Male|Unclassified Tumors|2018|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|31|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|41|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|43|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|42549015|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42549015|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|47|42367323|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42367323|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42176956|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42176956|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42036128|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42036128|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|44|41955322|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41955322|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|178|207689081|Male|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|117|207689081|Male|Unique astrocytoma variants|2014-2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|41934839|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41934839|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|37|41942505|Male|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41942505|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|41921243|Male|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41921243|Male|Unique astrocytoma variants|2017|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|41442486|Male|Unique astrocytoma variants|2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|22|41442486|Male|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83181748|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|72|406542905|Male and Female|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|300|406542905|Male and Female|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82080244|Male and Female|All other|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|All other|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82106582|Male and Female|All other|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|81129651|Male and Female|All other|2018|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Malignant|236|81129651|Male and Female|All other|2018|0.3|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|87|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|76|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83181748|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82826880|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|68|82482164|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|96|82244884|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|98|82105856|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|370|406542905|Male and Female|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|79|82080244|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|72|82106582|Male and Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|60|82062709|Male and Female|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|63|81129651|Male and Female|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|406542905|Male and Female|Anaplastic oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|178|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|206|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|83181748|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|185|82826880|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|165|82482164|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|193|82244884|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|82105856|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|898|406542905|Male and Female|Astrocytoma, NOS|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|82080244|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|174|82106582|Male and Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|179|82062709|Male and Female|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|167|81129651|Male and Female|Astrocytoma, NOS|2018|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|83181748|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|83181748|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82826880|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82826880|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82482164|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82482164|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82244884|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82244884|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82105856|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82105856|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|313|406542905|Male and Female|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|101|406542905|Male and Female|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82080244|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|82080244|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82106582|Male and Female|Choroid plexus|2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82106582|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82062709|Male and Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82062709|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|81129651|Male and Female|Choroid plexus|2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|81129651|Male and Female|Choroid plexus|2018|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|162|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|175|83181748|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83181748|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82826880|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82482164|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82244884|Male and Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82244884|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|198|82105856|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|834|406542905|Male and Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|406542905|Male and Female|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|177|82080244|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|142|82106582|Male and Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82106582|Male and Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|179|82062709|Male and Female|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82062709|Male and Female|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|81129651|Male and Female|Craniopharyngioma|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181748|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82826880|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82482164|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82244884|Male and Female|Diffuse astrocytoma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|406542905|Male and Female|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|509|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|498|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|519|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|489|83181748|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|497|82826880|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82482164|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|459|82244884|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|493|82105856|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.5|0.6|0.6|Malignant|2251|406542905|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.7|0.6|Malignant|489|82080244|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82106582|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.5|0.6|0.6|Malignant|470|82062709|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.5|0.4|Malignant|350|81129651|Male and Female|Embryonal/primitive/medulloblastoma|2018|0.4|0.5|0.4
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|83181748|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83181748|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82826880|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82826880|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82482164|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82482164|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82244884|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82244884|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|145|406542905|Male and Female|Ependymoma variants|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|406542905|Male and Female|Ependymoma variants|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82080244|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82080244|Male and Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82106582|Male and Female|Ependymoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82106582|Male and Female|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82062709|Male and Female|Ependymoma variants|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82062709|Male and Female|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|81129651|Male and Female|Ependymoma variants|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81129651|Male and Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|171|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83181748|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|213|82826880|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|82482164|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|204|82244884|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82105856|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|954|406542905|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|201|82080244|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|181|82106582|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|220|82062709|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|166|81129651|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|127|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|83181748|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|165|83181748|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82826880|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|82826880|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|82482164|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82482164|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|47|82244884|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|157|82244884|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|82105856|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|136|82105856|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|237|406542905|Male and Female|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|752|406542905|Male and Female|Germ Cell Tumors|2014-2018|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82080244|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|152|82080244|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|60|82106582|Male and Female|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|168|82106582|Male and Female|Germ Cell Tumors|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82062709|Male and Female|Germ Cell Tumors|2017|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|173|82062709|Male and Female|Germ Cell Tumors|2017|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|54|81129651|Male and Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|127|81129651|Male and Female|Germ Cell Tumors|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|122|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|118|83181748|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|160|82826880|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|155|82482164|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|163|82244884|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|145|82105856|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Glioblastoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|698|406542905|Male and Female|Glioblastoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|150|82080244|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|138|82106582|Male and Female|Glioblastoma|2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|140|82062709|Male and Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|131|81129651|Male and Female|Glioblastoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|462|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|489|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|513|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|553|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|570|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|21|83181748|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|550|83181748|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82826880|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|595|82826880|Male and Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|34|82482164|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|508|82482164|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|32|82244884|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|577|82244884|Male and Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|40|82105856|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|535|82105856|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|226|406542905|Male and Female|Glioma malignant, NOS|2014-2018|0.0|0.1|0.1
0-19|0.7|0.7|0.7|Malignant|2784|406542905|Male and Female|Glioma malignant, NOS|2014-2018|0.7|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|38|82080244|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|582|82080244|Male and Female|Glioma malignant, NOS|2015|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|53|82106582|Male and Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|608|82106582|Male and Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|43|82062709|Male and Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.8|0.8|Malignant|632|82062709|Male and Female|Glioma malignant, NOS|2017|0.7|0.8|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|53|81129651|Male and Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Malignant|445|81129651|Male and Female|Glioma malignant, NOS|2018|0.5|0.6|0.5
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|83181748|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83181748|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82826880|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82826880|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82482164|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82482164|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82244884|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82244884|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|82105856|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82105856|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|191|406542905|Male and Female|Hemangioblastoma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|406542905|Male and Female|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82080244|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82080244|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82106582|Male and Female|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82106582|Male and Female|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82062709|Male and Female|Hemangioblastoma|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82062709|Male and Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|81129651|Male and Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81129651|Male and Female|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|48|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|44|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|71|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|84|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|94|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|83181748|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|143|82826880|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|133|82482164|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|121|82244884|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82244884|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|124|82105856|Male and Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|596|406542905|Male and Female|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|406542905|Male and Female|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82080244|Male and Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82106582|Male and Female|Hemangioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82106582|Male and Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|82062709|Male and Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82062709|Male and Female|Hemangioma|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|81129651|Male and Female|Hemangioma|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81129651|Male and Female|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|406542905|Male and Female|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82482164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|406542905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82080244|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82106582|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83181748|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82826880|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82482164|Male and Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|135|82244884|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82244884|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|130|82105856|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|646|406542905|Male and Female|Meningioma|2014-2018|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|406542905|Male and Female|Meningioma|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|140|82080244|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|82106582|Male and Female|Meningioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82106582|Male and Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82062709|Male and Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82062709|Male and Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|81129651|Male and Female|Meningioma|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83181748|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82826880|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82482164|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82244884|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82105856|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|51|406542905|Male and Female|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|114|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|105|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|117|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|128|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|153|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|83181748|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83181748|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|138|82826880|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82826880|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|134|82482164|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|53|82482164|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|143|82244884|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82244884|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|150|82105856|Male and Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82105856|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|652|406542905|Male and Female|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|213|406542905|Male and Female|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|143|82080244|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82080244|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|120|82106582|Male and Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|46|82106582|Male and Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|118|82062709|Male and Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82062709|Male and Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|124|81129651|Male and Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|43|81129651|Male and Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|241|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|289|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|330|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|312|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|83181748|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181748|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|283|82826880|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82826880|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|301|82482164|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82482164|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|315|82244884|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82244884|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|254|82105856|Male and Female|Nerve sheath, benign and malignant|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82105856|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1257|406542905|Male and Female|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|406542905|Male and Female|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|310|82080244|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82080244|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|305|82106582|Male and Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82106582|Male and Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|233|82062709|Male and Female|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82062709|Male and Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|81129651|Male and Female|Nerve sheath, benign and malignant|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Neuroepithelial|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|40|406542905|Male and Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Neuroepithelial|2018|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|265|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|282|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|312|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|312|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|297|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|83181748|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83181748|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|344|82826880|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|36|82826880|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|361|82482164|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|37|82482164|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|351|82244884|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|46|82244884|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|333|82105856|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|56|82105856|Male and Female|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|1862|406542905|Male and Female|Neuronal/glial, neuronal|2014-2018|0.4|0.5|0.5
0-19|0.1|0.1|0.1|Malignant|240|406542905|Male and Female|Neuronal/glial, neuronal|2014-2018|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|386|82080244|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|42|82080244|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|412|82106582|Male and Female|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.1|0.1|0.1|Malignant|55|82106582|Male and Female|Neuronal/glial, neuronal|2016|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|397|82062709|Male and Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|39|82062709|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|345|81129651|Male and Female|Neuronal/glial, neuronal|2018|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|50|81129651|Male and Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83181748|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82826880|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|82482164|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82244884|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82105856|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|161|406542905|Male and Female|Oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82080244|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82106582|Male and Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Oligodendroglioma|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82062709|Male and Female|Oligodendroglioma|2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Oligodendroglioma|2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|81129651|Male and Female|Oligodendroglioma|2018|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|27|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|83181748|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|61|82826880|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82826880|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82482164|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82482164|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|75|82244884|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82244884|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|76|82105856|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82105856|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|438|406542905|Male and Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|64|406542905|Male and Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|85|82080244|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82080244|Male and Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|101|82106582|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82106582|Male and Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|92|82062709|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82062709|Male and Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|84|81129651|Male and Female|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81129651|Male and Female|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|700|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|675|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|687|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|732|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|721|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|775|83181748|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|755|82826880|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|807|82482164|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|1.0|Malignant|799|82244884|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|1.0|Malignant|788|82105856|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|1.0
0-19|0.0|0.0|0.0|Benign/Borderline|132|406542905|Male and Female|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|0.9|0.9|Malignant|3715|406542905|Male and Female|Pilocytic astrocytoma|2014-2018|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|739|82080244|Male and Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|0.9|0.9|Malignant|707|82106582|Male and Female|Pilocytic astrocytoma|2016|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|8
